Rebecca Burns - McGill University Health Centre

Canadian teenagers are among the largest consumers of cannabis worldwide. The damaging effects of this illicit drug on young brains are worse than originally thought, according to new research by Dr Gabriella Gobbi, a psychiatric researcher from the Research Institute of the McGill University Health Centre. The new study, published in Neurobiology of Disease, suggests that daily consumption of cannabis in teens can cause depression and anxiety, and have an irreversible long-term effect on the brain.
"We wanted to know what happens in the brains of teenagers when they use cannabis and whether they are more susceptible to its neurological effects than adults," explained Dr Gobbi, who is also a professor at McGill University. Her study points to an apparent action of cannabis on two important compounds in the brain - serotonin and norepinephrine (noradrenaline) - which are involved in the regulation of neurological functions such as mood control and anxiety.
"Teenagers who are exposed to cannabis have decreased serotonin transmission, which leads to mood disorders, as well as increased norepinephrine transmission, which leads to greater long-term susceptibility to stress," Dr Gobbi stated.
Previous epidemiological studies have shown how cannabis consumption can affect behavior in some teenagers. "Our study is one of the first to focus on the neurobiological mechanisms at the root of this influence of cannabis on depression and anxiety in adolescents," confirmed Dr Gobbi. It is also the first study to demonstrate that cannabis consumption causes more serious damage during adolescence than adulthood.
The study was funded by a grant from The Canadian Psychiatric Research Foundation (CPRF).
Bambico FR, Nguyen NT, Katz N, Gobbi G. Chronic Exposure to Cannabinoids during Adolescence but not during Adulthood Impairs Emotional Behaviour and Monoaminergic Neurotransmission. Neurobiol Dis. 2009 Dec;doi:10.1016/j.nbd.2009.11.020[Abstract]
This PR blurb is amazingly disingenuous. The study was done on adolescent
rats, not humans, and did not even involve marijuana, but instead a
synthetic marijuana analogue that has both a higher for CB1 receptors than
marijuana does, and also happens to be structurally quite different.
We could argue about some of the details, but I ran the "PR blurb"
unchanged and uncommented because the findings are in line with my
observations of humans, adolescents and adults, using street grade
cannabis.